• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Leadership Change Might Change The Case For Investing In Eurazeo (ENXTPA:RF)

    Simply Wall St·11/07/2026 05:26:44
    Listen to the news
    • Eurazeo appointed Christophe Bavière as sole Chairman of the Executive Board, reshaping its governance ahead of current mandate expiries in February 2027.
    • The governance reset comes after a multi year shift toward third party asset management. This raises fresh questions about execution, cost discipline, and fee growth.
    • The focus now turns to how Eurazeo's investment narrative could evolve as governance centralizes under Christophe Bavière's sole leadership.

    Scan how Eurazeo’s governance reset compares to other asset managers repositioning for fee based growth by reviewing the curated list of 588 high quality undiscovered gems.

    Eurazeo Investment Narrative Recap

    To own Eurazeo, you need to believe in its shift toward fee based asset management with higher third party assets and improving FRE margins, while accepting the drag from legacy buyout exposures and an uncovered 6.5% dividend. The near term focus sits on execution, from fundraising traction to discipline on costs and capital deployment.

    The upcoming Q3 2026 sales and trading statement on 5 November is the clearest short term catalyst, because it updates on fee income and asset rotation. The biggest risk right now is further valuation pressure or write downs in older portfolios, which could offset fee growth and keep reported earnings volatile.

    The governance change that puts Christophe Bavière as sole Chairman of the Executive Board is the announcement that most directly frames this catalyst. A more centralized structure may clarify accountability around fundraising, FRE margin progress and decisions on balance sheet recycling, all key areas investors watch when Eurazeo reports quarterly trends.

    This shift also lands against a mixed backdrop, with the share price below some analyst targets and long term losses and an uncovered dividend raising questions about payout sustainability. Attention on the 5 November update will likely center on how the business balances fee growth, asset rotations and cash returns within this new leadership setup.

    Eurazeo's current narrative implies revenue of €920.5 million and earnings of €475.0 million by 2029. This rests on analysts assuming very large yearly revenue growth of 178.3% and an earnings swing of about €878.5 million from a loss of €403.5 million today to those forecast profits.

    Uncover why Eurazeo's fair value indicates a potential 47% upside to its current price before that discount starts to close.

    ENXTPA:RF 1-Year Stock Price Chart
    ENXTPA:RF 1-Year Stock Price Chart

    Exploring Other Perspectives

    Some of the lowest Eurazeo forecasts paint a very different picture. Those analysts were only pencilling in revenue of about €513.2 million and earnings of €308.1 million by 2029, well below the consensus view. You might read the Q3 2026 update and governance change and decide their slower fee based growth story needs to be reconsidered.

    Explore 2 other Eurazeo fair value estimates, including one that suggests it could be worth just €52.40.

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Looking For More Investment Ideas Beyond Eurazeo?

    If the Eurazeo story has sharpened your thinking about fees, balance sheets and payout risk, it can help to compare it with other listed companies that share some of those traits. The Simply Wall St Screener lets you quickly scan different corners of the market so you can pressure test your thesis against a broader watchlist.